Title:
ACSMs guidelines for exercise testing and prescription
Edition:
7th ed
Publication Information:
Philadelphia, PA : Lippincott Williams & Wilkins, 2006
ISBN:
9780781745901
Available:*
Library | Item Barcode | Call Number | Material Type | Item Category 1 | Status |
---|---|---|---|---|---|
Searching... | 30000010156163 | RM725 A43 2006 | Open Access Book | Book | Searching... |
On Order
Summary
Summary
The single most internationally read and referenced text in sports medicine, exercise science, and health and fitness, this manual succinctly summarizes recommended procedures for exercise testing and exercise prescription in healthy and diseased individuals. The Seventh Edition contains the most current public health and clinical information and state-of-the-art, research-based recommendations.
Coverage represents the fundamental knowledge, skills, and abilities (KSAs) that must be mastered by candidates for all ACSM certifications. Written by international experts in numerous fields, the Seventh Edition covers additional topics including arthritis, osteoporosis, dyslipidemia, immunology, and metabolic syndrome.
Table of Contents
Preface | p. vii |
Nota Bene | p. x |
Contributors | p. xi |
Abbreviations | p. xix |
Section I Health Appraisal, Risk Assessment, and Safety of Exercise | |
1 Benefits and Risks Associated With Physical Activity | p. 3 |
Physical Activity and Fitness Terminology | p. 3 |
Public Health Perspective for Current Recommendations | p. 5 |
Divergent Physical Activity Recommendations | p. 6 |
Benefits of Regular Physical Activity and/or Exercise | p. 7 |
Dose-Response Relationship | p. 7 |
Risks Associated With Exercise | p. 10 |
Sudden Death Among Young Individuals | p. 11 |
Exercise Events in Those With Sickle Cell Trait | p. 12 |
Exercise-Related Cardiac Events in Adults | p. 12 |
Risks of Cardiac Events During Exercise Testing | p. 12 |
Risks of Cardiac Events During Cardiac Rehabilitation | p. 13 |
Prevention of Exercise-Related Cardiac Events | p. 13 |
2 Preparticipation Health Screening and Risk Stratification | p. 19 |
Preparticipation Screening Algorithm | p. 19 |
Risk Stratification and Medical Clearance | p. 21 |
Additional Preparticipation Assessments | p. 28 |
Exercise Testing and Testing Supervision Recommendations | p. 29 |
Risk Stratification for Cardiac Patients | p. 30 |
Section II Exercise Testing | |
3 Pre-Exercise Evaluations | p. 39 |
Medical History, Physical Examination, and Laboratory Tests | p. 39 |
Blood Pressure | p. 43 |
Lipids and Lipoproteins | p. 45 |
Blood Profile Analyses | p. 46 |
Pulmonary Function | p. 47 |
Contraindications to Exercise Testing | p. 49 |
Informed Consent | p. 49 |
Participant Instructions | p. 51 |
4 Health-Related Physical Fitness Testing and Interpretation | p. 55 |
Purposes of Health-Related Fitness Testing | p. 55 |
Basic Principles and Guidelines | p. 56 |
Pretest Instructions | p. 56 |
Test Order | p. 56 |
Test Environment | p. 56 |
Body Composition | p. 57 |
Anthropometric Methods | p. 57 |
Densitometry | p. 64 |
Other Techniques | p. 65 |
Body Composition Norms | p. 66 |
Cardiorespiratory Fitness | p. 66 |
The Concept of Maximal Oxygen Uptake | p. 66 |
Maximal versus Submaximal Exercise Testing | p. 67 |
Modes of Testing | p. 68 |
Cardiorespiratory Test Sequence and Measures | p. 76 |
Test Termination Criteria | p. 78 |
Interpretation of Results | p. 79 |
Muscular Strength and Muscular Endurance | p. 80 |
Muscular Strength | p. 81 |
Muscular Endurance | p. 83 |
Flexibility | p. 85 |
A Comprehensive Health Fitness Evaluation | p. 89 |
5 Clinical Exercise Testing | p. 93 |
Indications and Applications | p. 93 |
Diagnostic Exercise Testing | p. 93 |
Exercise Testing for Disease Severity and Prognosis | p. 94 |
Exercise Testing After Myocardial Infarction | p. 94 |
Functional Exercise Testing | p. 95 |
Exercise Test Modalities | p. 96 |
Exercise Protocols | p. 99 |
Upper Body Exercise Testing | p. 102 |
Testing for Return to Work | p. 102 |
Measurements During Exercise Testing | p. 103 |
Heart Rate and Blood Pressure | p. 103 |
Electrocardiographic Monitoring | p. 105 |
Subjective Ratings and Symptoms | p. 106 |
Gas Exchange and Ventilatory Responses | p. 107 |
Blood Gases | p. 108 |
Indications for Exercise Test Termination | p. 108 |
Postexercise Period | p. 108 |
Exercise Testing With Imaging Modalities | p. 110 |
Exercise Echocardiography | p. 110 |
Exercise Nuclear Imaging | p. 110 |
Pharmacologic Stress Testing | p. 111 |
Electron Beam Computed Tomography | p. 111 |
Supervision of Exercise Testing | p. 112 |
6 Interpretation of Clinical Exercise Test Data | p. 115 |
Exercise Testing As a Screening Tool for Coronary Artery Disease | p. 115 |
Interpretation of Responses to Graded Exercise Testing | p. 116 |
Heart Rate Response | p. 116 |
Blood Pressure Response | p. 119 |
Electrocardiographic Waveforms | p. 119 |
Limiting Signs and Symptoms | p. 123 |
Gas Exchange and Ventilatory Responses | p. 123 |
Diagnostic Value of Exercise Testing | p. 124 |
Sensitivity | p. 124 |
Specificity | p. 125 |
Predictive Value | p. 125 |
Comparison With Imaging Stress Tests | p. 126 |
Prognostic Applications of the Exercise Test | p. 126 |
Section III Exercise Prescription | |
7 General Principles of Exercise Prescription | p. 133 |
Principles of Training | p. 134 |
Overview of the Exercise Prescription | p. 135 |
The Art of Exercise Prescription | p. 136 |
Components of the Training Session | p. 136 |
Warm-up | p. 137 |
Stimulus or Conditioning Phase | p. 138 |
Recreational Activities | p. 138 |
Cool-Down | p. 138 |
Cardiorespiratory Exercise Prescription | p. 139 |
Mode of Exercise | p. 139 |
Exercise Intensity | p. 141 |
Exercise Duration | p. 146 |
Energy Expenditure Goals | p. 148 |
Rate of Progression | p. 149 |
Initial Conditioning Stage | p. 150 |
Improvement Stage | p. 150 |
Maintenance Stage | p. 151 |
Training Specificity | p. 151 |
Summary of Guidelines for Cardiovascular Stimulus Phase | p. 153 |
Resistance Exercise Prescription | p. 154 |
Flexibility Exercise Prescription | p. 158 |
Maintenance of the Training Effect | p. 160 |
Program Supervision | p. 161 |
Methods for Changing Exercise Behaviors | p. 163 |
Strategies for Increasing Exercise Adherence | p. 165 |
Encourage Lifestyle Physical Activity | p. 165 |
8 Exercise Prescription Modifications for Cardiac Patients | p. 174 |
Inpatient Rehabilitation Programs | p. 174 |
Outpatient Exercise Programs | p. 177 |
Exercise Intensity for the Cardiac Patient | p. 178 |
Modes of Exercise for Cardiac Patients | p. 181 |
Progression of Exercise for the Cardiac Patient | p. 182 |
Recommended Total Dose or Volume of Exercise for Cardiac Patients | p. 183 |
Exercise Prescription Without a Preliminary Exercise Test | p. 184 |
Types of Outpatient Programs | p. 186 |
Benefits of Endurance Training in Cardiac Patients | p. 188 |
Resistance Training for Cardiac Patients | p. 189 |
Eligibility and Exclusion Criteria for Resistance Training | p. 189 |
Time Course for Resistance Training | p. 190 |
Resistance Training Prescription for Cardiac Patients | p. 190 |
Exercise Training for Return to Work | p. 191 |
Special Cardiac Patient Populations | p. 191 |
Myocardial Ischemia | p. 191 |
Congestive Heart Failure | p. 193 |
Pacemakers and Implantable Cardioverter Defibrillators | p. 194 |
Cardiac Transplant Recipient | p. 197 |
Cardiac Surgery and Percutaneous Transluminal Coronary Intervention | p. 199 |
9 Other Clinical Conditions Influencing Exercise Prescription | p. 205 |
Arthritis | p. 205 |
Exercise Testing | p. 206 |
Exercise Prescription | p. 206 |
Special Considerations | p. 207 |
Diabetes Mellitus | p. 207 |
Exercise Testing | p. 208 |
Exercise Prescription | p. 208 |
Special Considerations | p. 210 |
Dyslipidemia | p. 211 |
Exercise Testing | p. 212 |
Exercise Prescription | p. 212 |
Special Considerations | p. 212 |
Hypertension | p. 213 |
Exercise Testing | p. 214 |
Exercise Prescription | p. 215 |
Special Considerations | p. 215 |
Obesity | p. 216 |
Exercise Testing | p. 217 |
Exercise Prescription | p. 217 |
Special Considerations | p. 218 |
Recommended Weight Loss Programs | p. 218 |
Metabolic Syndrome | p. 219 |
Exercise Testing and Prescription | p. 220 |
Immunology | p. 221 |
Exercise and Upper Respiratory Tract Infections | p. 221 |
Immune Responses to Exercise | p. 222 |
Exercise Testing | p. 222 |
Exercise Prescription | p. 223 |
Special Considerations | p. 223 |
Osteoporosis | p. 223 |
Exercise Testing | p. 224 |
Exercise Prescription | p. 224 |
Special Considerations | p. 225 |
Peripheral Arterial Disease | p. 225 |
Exercise Testing | p. 226 |
Exercise Prescription | p. 226 |
Special Considerations | p. 226 |
Pulmonary Diseases | p. 227 |
Exercise Testing | p. 227 |
Exercise Prescription | p. 228 |
Special Considerations | p. 229 |
Pregnancy | p. 229 |
Exercise Testing | p. 231 |
Exercise Prescription | p. 231 |
Special Considerations | p. 231 |
10 Exercise Testing and Prescription for Children and Elderly People | p. 237 |
Children | p. 237 |
Clinical Laboratory Testing | p. 237 |
Fitness Testing | p. 240 |
Exercise Prescription | p. 241 |
Elderly People | p. 246 |
Exercise Testing | p. 246 |
Exercise Prescription | p. 247 |
Section IV Appendices | |
A Common Medications | p. 255 |
B Emergency Management | p. 267 |
C Electrocardiogram (ECG) Interpretation | p. 279 |
D Metabolic Calculations | p. 286 |
E Environmental Considerations | p. 300 |
F American College of Sports Medicine Certifications | p. 309 |
Index | p. 351 |